Aslan Pharmaceuticals Ltd
Change company Symbol lookup
Select an option...
ASLN Aslan Pharmaceuticals Ltd
GOTU GSX Techedu Inc
APG APi Group Corp
TWTR Twitter Inc
WEX WEX Inc
BBY Best Buy Co Inc
PLX Protalix Biotherapeutics Inc
JPM JPMorgan Chase & Co
KMB Kimberly-Clark Corp
PWR Quanta Services Inc
Go

Health Care : Biotechnology |
Based in Singapore
Company profile

ASLAN Pharmaceuticals Limited (ASLAN) is a clinical-stage immunology and oncology-focused biopharmaceutical company. ASLAN has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$2.57
Day's Change
0.07 (2.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.66
Day's Low
2.52
Volume
(Average)
Volume:
317,205

10-day average volume:
322,043
317,205
  • Prev Close
    2.50
  • Today's Open
    2.52
  • Day's Range
    2.52-2.66
  • Avg Vol (10-day)
    322.0K
  • Last (time)
    3:59p ET 05/14/21
  • Last (size)
    1
  • 52-Wk Range
    1.26 - 6.75
    LowHigh
  • (09/04/20 - 03/01/21)
    103.97%
  • 80.0%
  • Market Cap
    178.7M
  • Shares Outstanding
    69.5M
  • -1.34
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 15.34
  • (% of float 04/30/21)
    6.20

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.